Magazine Article | March 8, 2017

Pharma Field Trips: Is Hosting The FDA A Good Idea?

Source: Life Science Leader

By Gail Dutton, Contributing Editor
Follow Me On Twitter @GailLdutton

Inviting FDA scientists into your manufacturing facility or laboratory for one or two days may feel unsettling, but it can be rewarding when the visits are designed to bring FDA scientists up to speed on real-world issues and new technologies.

Drug developers can learn the extent of that potential benefit in 2017 when CDER launches the Staff Experiential Learning Site Visit Program. The educational program focuses on 17 areas of scientific interest, ranging from drug/device combo products to continuous manufacturing, nanotech, and APIs. It is expected to start during the first half of 2017, once CDER receives and approves appropriate applications from pharmas to host FDA scientists for one- to two-day learning visits.